Vaxcyte (PCVX) News Today $71.67 -2.15 (-2.92%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 11,620 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Cibc World Markets CorpCibc World Markets Corp purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 11,620 shares of the company's stock, valued at approximately $951,000. A nuMarch 23 at 4:10 AM | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of "Buy" from AnalystsVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) has received a consensus recommendation of "Buy" from the nine brokerages that are covering the stock, MarketBeat reports. Nine investment analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issuMarch 22 at 2:19 AM | marketbeat.comLazard US Equity Concentrated Portfolio Q4 2024 CommentaryMarch 20, 2025 | seekingalpha.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Swiss National BankSwiss National Bank boosted its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 21.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 219,000 shares of the company's stock after acquiring an additional 38,400 sharesMarch 19, 2025 | marketbeat.comProficio Capital Partners LLC Makes New $2.92 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX)Proficio Capital Partners LLC acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 35,609 shares of the company's stock, valued at approxMarch 19, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 37.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,199 shares ofMarch 17, 2025 | marketbeat.comGreat Lakes Advisors LLC Takes Position in Vaxcyte, Inc. (NASDAQ:PCVX)Great Lakes Advisors LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 43,466 shares of the company's stock, valued at approximately $3,558,000. SeMarch 16, 2025 | marketbeat.comAGF Management Ltd. Buys New Shares in Vaxcyte, Inc. (NASDAQ:PCVX)AGF Management Ltd. bought a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 28,444 shares of the company's stock, valued at approximately $2,328,000. A number of othMarch 16, 2025 | marketbeat.comRaymond James Financial Inc. Takes $21.67 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)Raymond James Financial Inc. acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 264,704 shares of the company's stock, valueMarch 16, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Given "Buy" Rating at GuggenheimGuggenheim restated a "buy" rating and set a $160.00 price target on shares of Vaxcyte in a research report on Wednesday.March 13, 2025 | marketbeat.comAmundi Sells 27,864 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Amundi decreased its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 6.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 406,928 shares of the company's stock after selling 27,864 shares during the period. AmundMarch 13, 2025 | marketbeat.comArizona State Retirement System Purchases 5,628 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Arizona State Retirement System increased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 21.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,256 shares of the company's stock aMarch 11, 2025 | marketbeat.comVictory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company's stock after purchasing an additional 48,516March 11, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,341,773 shares of the company's stock after acquiring an additional 45,936 shares during theMarch 9, 2025 | marketbeat.comE Fund Management Co. Ltd. Grows Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)E Fund Management Co. Ltd. grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 152.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 10,479 shares of the company's stock after purchasing an additional 6,335 shares during the period.March 8, 2025 | marketbeat.comCandriam S.C.A. Buys New Shares in Vaxcyte, Inc. (NASDAQ:PCVX)Candriam S.C.A. bought a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 114,110 shares of the company's stock, valued at approximately $9,341,March 8, 2025 | marketbeat.com4,538 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Acquired by Aigen Investment Management LPAigen Investment Management LP acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,538 shares of the company's stock, valued at approximately $371,000. Other heMarch 8, 2025 | marketbeat.comMutual of America Capital Management LLC Lowers Stake in Vaxcyte, Inc. (NASDAQ:PCVX)Mutual of America Capital Management LLC lessened its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 49.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,270 shares of the compaMarch 8, 2025 | marketbeat.comBank of New York Mellon Corp Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Bank of New York Mellon Corp boosted its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 421,938 shares of the company's stock after acquiring anMarch 8, 2025 | marketbeat.comProficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX)Proficio Capital Partners LLC bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 35,609 shares of the company's stock,March 6, 2025 | marketbeat.comInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) COO Sells 8,000 Shares of StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) COO Jim Wassil sold 8,000 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $73.27, for a total transaction of $586,160.00. Following the sale, the chief operating officer now directly owns 154,931 shares in the company, valued at approximately $11,351,794.37. The trade was a 4.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.March 5, 2025 | marketbeat.comVaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy NowMarch 4, 2025 | insidermonkey.comVaxcyte, Inc. (NASDAQ:PCVX) COO Sells $586,160.00 in StockMarch 4, 2025 | insidertrades.comResearch Analysts Offer Predictions for Vaxcyte Q1 EarningsVaxcyte, Inc. (NASDAQ:PCVX - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Vaxcyte in a report released on Tuesday, February 25th. Leerink Partnrs analyst D. Risinger expects that the company will post earnings per share of ($1.01) for thMarch 1, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund lessened its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 17.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,295 shares of the company's stock aMarch 1, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Announces Quarterly Earnings Results, Beats Expectations By $0.14 EPSVaxcyte (NASDAQ:PCVX - Get Free Report) released its earnings results on Tuesday. The company reported ($1.02) EPS for the quarter, topping the consensus estimate of ($1.16) by $0.14.February 26, 2025 | marketbeat.comGuggenheim Reiterates Buy Rating for Vaxcyte (NASDAQ:PCVX)Guggenheim reaffirmed a "buy" rating and issued a $160.00 target price on shares of Vaxcyte in a research report on Wednesday.February 26, 2025 | marketbeat.comVaxcyte, Inc.: Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateFebruary 26, 2025 | finanznachrichten.deNeedham & Company LLC Reiterates Buy Rating for Vaxcyte (NASDAQ:PCVX)Needham & Company LLC restated a "buy" rating and issued a $140.00 price target on shares of Vaxcyte in a research report on Wednesday.February 26, 2025 | marketbeat.comVaxcyte, Inc. (PCVX) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comVaxcyte, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 26, 2025 | seekingalpha.comVaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateFebruary 25, 2025 | globenewswire.comVaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to AnalystsFebruary 25, 2025 | msn.comHandelsbanken Fonder AB Has $2.58 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Handelsbanken Fonder AB increased its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 16.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 31,500 shares of the company's stock after purchasing an additional 4,400 shares during the period. HanFebruary 25, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Buy" from BrokeragesVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) has earned an average rating of "Buy" from the eight research firms that are currently covering the company, MarketBeat reports. Eight analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issFebruary 25, 2025 | marketbeat.comPrincipal Financial Group Inc. Has $25.29 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX)Principal Financial Group Inc. increased its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 486.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 308,939 shares of the company's stock after buying an additional 256,237 shares during thFebruary 23, 2025 | marketbeat.comRhumbline Advisers Buys 7,711 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Rhumbline Advisers grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 171,814 shares of the company's stock after acquiring an additional 7,711 shares during the quarterFebruary 23, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) CFO Sells $670,800.00 in StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $83.85, for a total value of $670,800.00. Following the completion of the transaction, the chief financial officer now owns 109,491 shares in the company, valued at $9,180,820.35. This trade represents a 6.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.February 20, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) CFO Andrew Guggenhime Sells 8,000 SharesFebruary 20, 2025 | insidertrades.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by State of New Jersey Common Pension Fund DState of New Jersey Common Pension Fund D grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 13.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,901 shares of tFebruary 20, 2025 | marketbeat.comTimesSquare Capital Management LLC Boosts Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)TimesSquare Capital Management LLC lifted its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 53.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 413,637 shares of the company's stock afteFebruary 19, 2025 | marketbeat.comVaxcyte (PCVX) Expected to Announce Earnings on TuesdayVaxcyte (NASDAQ:PCVX) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=665623)February 18, 2025 | marketbeat.comBanque Pictet & Cie SA Sells 5,457 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Banque Pictet & Cie SA lowered its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 59,315 shares of the company's stockFebruary 15, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Grows Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Allspring Global Investments Holdings LLC lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 70.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 593,523 shares of the company's stock after buFebruary 14, 2025 | marketbeat.comVaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025February 12, 2025 | globenewswire.comWCM Investment Management LLC Reduces Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)WCM Investment Management LLC reduced its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 48.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 72,094 shares of the company's stock after selling 68,February 10, 2025 | marketbeat.com12 Best Healthcare Stocks to Buy According to AnalystsFebruary 9, 2025 | insidermonkey.comVaxcyte SVP Mikhail Eydelman sells $450k in stockFebruary 8, 2025 | msn.comWhy Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to AnalystsFebruary 8, 2025 | msn.comabrdn plc Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)abrdn plc lifted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 171.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 224,824 shares of the company's stock after buying an additional 141,9February 7, 2025 | marketbeat.com Remove Ads Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCVX Media Mentions By Week PCVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼1.260.63▲Average Medical News Sentiment PCVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼56▲PCVX Articles Average Week Remove Ads Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Intra-Cellular Therapies News Today Moderna News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Viatris News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
